top of page

PRD961

Prostate disease tissue array, 48 cases of normal, hyperplastic and neoplastic prostate tissues in duplicates.

Specification

Images

Data Sheet

TNM Grading

Downloads

Price

Size

Availability

$352

1 slide

In-Stock

A
B
C
D
E
F
G
H
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg

TNM Classification : Prostate carcinoma

 

T- Primary tumor

TX - Primary tumor cannot be assessed

TO - No evidence of primary tumor

T1 - Clinically inapparant tumor not palpable or visible by imaging

T1a - Tumor incidental histologic findings in 5% or less of tissue resected

T1 b - Tumor incidental histologic findings in more than 5% of tissue resected

T1c - Tumor identified by needle biopsy

T2 - Tumor confined within the prostate

T2a - Tumor involves one lobe

T2b - Tumor involves two lobes

T3 - Tumor extends through the prostate capsule

T3a - Extracapsular extension

T3b - Tumor invades seminal vesicle

T4 - Tumor is fixed or invades adjacent structures other than seminal vesicle: (bladder neck, external sphincter, rectum, levator muscle and/or pelvic wall


N - Regional lymph nodes

NX - Regional lymph nodes cannot be assessed

NO - No regional lymph node metastasis

N1 - Regional lymph node metastasis


M - Distant metastasis

MX - Distant metastasis cannot be assessed

MO - No distant metastasis

M1 - Distant metastasis

M1a - Non-regional lymph node(s)

M1b-Bone(s)

M1c-Other site(s)

Species

Human

Cases

48

Cores

96

Core Diameter

1.5mm

Core Thickness

4um

Rows

8

Columns

12

Tissue Type

Paraffin

Notes:

All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.

​

Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.

Recommended Application

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in common diseases of the prostate.

4X6b.jpg

​

ARRAY POSITION
IMAGE
SEX
AGE
ANATOMIC SITE
PATHOLOGY
GRADE
STAGE (TNM)
A01
M
72
Prostate
Hyperplasia
A02
M
85
Prostate
Hyperplasia
A03
M
67
Prostate
Hyperplasia
A04
M
63
Prostate
Hyperplasia
A05
M
76
Prostate
Hyperplasia
A06
M
73
Prostate
Hyperplasia
A07
M
58
Prostate
Hyperplasia
A08
M
65
Prostate
Hyperplasia
A09
M
80
Prostate
Hyperplasia
A10
M
68
Prostate
Hyperplasia
A11
M
70
Prostate
Hyperplasia
A12
M
66
Prostate
Hyperplasia
B01
M
72
Prostate
Hyperplasia
B02
M
85
Prostate
Hyperplasia
B03
M
67
Prostate
Hyperplasia
B04
M
63
Prostate
Hyperplasia
B05
M
76
Prostate
Hyperplasia
B06
M
73
Prostate
Hyperplasia
B07
M
58
Prostate
Hyperplasia
B08
M
65
Prostate
Hyperplasia
B09
M
80
Prostate
Hyperplasia
B10
M
68
Prostate
Hyperplasia
B11
M
70
Prostate
Hyperplasia
B12
M
66
Prostate
Hyperplasia
C01
M
65
Prostate
Hyperplasia
C02
M
64
Prostate
Hyperplasia
C03
M
61
Prostate
Hyperplasia
C04
M
74
Prostate
Hyperplasia
C05
M
68
Prostate
Hyperplasia
C06
M
71
Prostate
Hyperplasia
C07
M
73
Prostate
Hyperplasia
C08
M
63
Prostate
Hyperplasia
C09
M
76
Prostate
Hyperplasia
C10
M
66
Prostate
Hyperplasia
C11
M
68
Prostate
Hyperplasia
C12
M
82
Prostate
Hyperplasia
D01
M
65
Prostate
Hyperplasia
D02
M
64
Prostate
Hyperplasia
D03
M
61
Prostate
Hyperplasia
D04
M
74
Prostate
Hyperplasia
D05
M
68
Prostate
Hyperplasia
D06
M
71
Prostate
Hyperplasia
D07
M
73
Prostate
Hyperplasia
D08
M
63
Prostate
Hyperplasia
D09
M
76
Prostate
Hyperplasia
D10
M
66
Prostate
Hyperplasia
D11
M
68
Prostate
Hyperplasia
D12
M
82
Prostate
Hyperplasia
E01
M
76
Prostate
Hyperplasia
E02
M
63
Prostate
Hyperplasia
E03
M
74
Prostate
Hyperplasia
E04
M
60
Prostate
Hyperplasia
E05
M
83
Prostate
Hyperplasia
E06
M
76
Prostate
Hyperplasia
E07
M
77
Prostate
Hyperplasia
E08
M
75
Prostate
Hyperplasia
E09
M
64
Prostate
Hyperplasia
E10
M
65
Prostate
Hyperplasia
E11
M
68
Prostate
Leiomyoma
E12
M
43
Prostate
Leiomyoma
F01
M
76
Prostate
Hyperplasia
F02
M
63
Prostate
Hyperplasia
F03
M
74
Prostate
Hyperplasia
F04
M
60
Prostate
Hyperplasia
F05
M
83
Prostate
Hyperplasia
F06
M
76
Prostate
Hyperplasia
F07
M
77
Prostate
Hyperplasia
F08
M
75
Prostate
Hyperplasia
F09
M
64
Prostate
Hyperplasia
F10
M
65
Prostate
Hyperplasia
F11
M
68
Prostate
Leiomyoma
F12
M
43
Prostate
Leiomyoma
G01
M
67
Prostate
Adenocarcinoma
I
T2N0M0
G02
M
51
Prostate
Adenocarcinoma
II
T3N1M0
G03
M
79
Prostate
Adenocarcinoma
II
T2N0M0
G04
M
71
Prostate
Adenocarcinoma
II
T3N1M0
G05
M
75
Prostate
Adenocarcinoma
II
T2N0M0
G06
M
73
Prostate
Adenocarcinoma
II
T2N0M0
G07
M
76
Prostate
Adenocarcinoma
II
T2N0M0
G08
M
76
Prostate
Adenocarcinoma
II
T1N0M0
G09
M
66
Prostate
Adenocarcinoma
III
T1N0M0
G10
M
73
Prostate
Adenocarcinoma
III
T2N0M0
G11
M
85
Prostate
Adenocarcinoma
III
T2N0M0
G12
M
71
Prostate
Adenocarcinoma
III
T2N0M0
H01
M
67
Prostate
Adenocarcinoma
I
T2N0M0
H02
M
51
Prostate
Adenocarcinoma
II
T3N1M0
H03
M
79
Prostate
Adenocarcinoma
II
T2N0M0
H04
M
71
Prostate
Adenocarcinoma
II
T3N1M0
H05
M
75
Prostate
Adenocarcinoma
II
T2N0M0
H06
M
73
Prostate
Adenocarcinoma
II
T2N0M0
H07
M
76
Prostate
Adenocarcinoma
II
T2N0M0
H08
M
76
Prostate
Adenocarcinoma
II
T1N0M0
H09
M
66
Prostate
Adenocarcinoma
III
T1N0M0
H10
M
73
Prostate
Adenocarcinoma
III
T2N0M0
H11
M
85
Prostate
Adenocarcinoma
III
T2N0M0
H12
M
71
Prostate
Adenocarcinoma
III
T2N0M0
null

Download Data Sheet

bottom of page